BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 32292341)

  • 1. Molecular Targets for Combined Therapeutic Strategies to Limit Glioblastoma Cell Migration and Invasion.
    Yool AJ; Ramesh S
    Front Pharmacol; 2020; 11():358. PubMed ID: 32292341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aquaporins and Ion Channels as Dual Targets in the Design of Novel Glioblastoma Therapeutics to Limit Invasiveness.
    Varricchio A; Yool AJ
    Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Inhibition of Membrane Signaling Mechanisms Reduces the Invasiveness of U87-MG and U251-MG Glioblastoma Cells In Vitro.
    Varricchio A; Khan S; Price ZK; Davis RA; Ramesh SA; Yool AJ
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Ion Channel Targets and Drug Delivery Tools for Controlling Glioblastoma Cell Invasiveness.
    Varricchio A; Ramesh SA; Yool AJ
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of natural polyphenols against glioblastoma.
    Beylerli O; Beilerli A; Shumadalova A; Wang X; Yang M; Sun H; Teng L
    Front Cell Dev Biol; 2022; 10():1036809. PubMed ID: 36268515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Invasion in Glioblastoma: Extracellular Matrix, Ca
    So JS; Kim H; Han KS
    Front Cell Neurosci; 2021; 15():663092. PubMed ID: 34149360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate Receptors and Glioblastoma Multiforme: An Old "Route" for New Perspectives.
    Corsi L; Mescola A; Alessandrini A
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30978987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
    Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
    J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma.
    Maier JP; Ravi VM; Kueckelhaus J; Behringer SP; Garrelfs N; Will P; Sun N; von Ehr J; Goeldner JM; Pfeifer D; Follo M; Hannibal L; Walch AK; Hofmann UG; Beck J; Heiland DH; Schnell O; Joseph K
    Cell Death Dis; 2021 Jul; 12(8):723. PubMed ID: 34290229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ion Channels as Therapeutic Targets in High Grade Gliomas.
    Griffin M; Khan R; Basu S; Smith S
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33096667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt/β-catenin Antagonists: Exploring New Avenues to Trigger Old Drugs in Alleviating Glioblastoma Multiforme.
    Precilla DS; Kuduvalli SS; Purushothaman M; Marimuthu P; Muralidharan AR; Anitha TS
    Curr Mol Pharmacol; 2022; 15(2):338-360. PubMed ID: 33881978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.
    Tabuchi S
    Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Calcium Signaling in Glioblastoma Multiforme: A Therapeutic Promise for Natural Products.
    Afshari AR; Mollazadeh H; Soukhtanloo M; Hosseini A; Mohtashami E; Jalili-Nik M; Modaresi SMS; Soltani A; Sahebkar A
    Mini Rev Med Chem; 2020; 20(18):1879-1899. PubMed ID: 32767939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the Role of Glutamate Signaling in Glioblastoma Multiforme: Current Therapeutic Modalities and Future Directions.
    Mollazadeh H; Mohtashami E; Mousavi SH; Soukhtanloo M; Vahedi MM; Hosseini A; Afshari AR; Sahebkar A
    Curr Pharm Des; 2020; 26(37):4777-4788. PubMed ID: 32493186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics to identify proteins interacting with P2X2 ligand-gated cation channels.
    Singh H; Warburton S; Vondriska TM; Khakh BS
    J Vis Exp; 2009 May; (27):. PubMed ID: 19455095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic Screening of Chemical Libraries Enriched by Molecular Docking to Multiple Targets Selected from Glioblastoma Genomic Data.
    Xu D; Zhou D; Bum-Erdene K; Bailey BJ; Sishtla K; Liu S; Wan J; Aryal UK; Lee JA; Wells CD; Fishel ML; Corson TW; Pollok KE; Meroueh SO
    ACS Chem Biol; 2020 Jun; 15(6):1424-1444. PubMed ID: 32243127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ion channel expression patterns in glioblastoma stem cells with functional and therapeutic implications for malignancy.
    Pollak J; Rai KG; Funk CC; Arora S; Lee E; Zhu J; Price ND; Paddison PJ; Ramirez JM; Rostomily RC
    PLoS One; 2017; 12(3):e0172884. PubMed ID: 28264064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.
    Verdugo E; Puerto I; Medina MÁ
    Cancer Commun (Lond); 2022 Nov; 42(11):1083-1111. PubMed ID: 36129048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the molecular mechanisms of migration and invasion in glioblastoma multiforme.
    Liu X; Chen JY; Chien Y; Yang YP; Chen MT; Lin LT
    J Chin Med Assoc; 2021 Jul; 84(7):669-677. PubMed ID: 34029218
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.